Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients
Sanna, G., Pestrin, M., Zafarana, E., Biagioni, C., Cavaciocchi, D., Turner, N., Di Leo, A., Biganzoli, L.Volume:
22
Language:
english
Journal:
The Breast
DOI:
10.1016/j.breast.2013.04.019
Date:
October, 2013
File:
PDF, 348 KB
english, 2013